melatonin and ml 23

melatonin has been researched along with ml 23 in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	5 (45.45)	18.7374
1990's	3 (27.27)	18.2507
2000's	3 (27.27)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Buzzell, GR; McNeill, ME; Menendez-Pelaez, A; Reiter, RJ; Troiani, ME	1
Kelly, RW; Lincoln, GA	1
Migliaccio, S; Nordio, M; Reiter, RJ; van Jaarsveld, A; Vaughan, MK; Zisapel, N	1
Chantegrel, J; Claustrat, B; Luu-Duc, C; Marsura, A; Masson-Pévet, M; Pévet, P	1
Laudon, M; Yaron, Z; Zisapel, N	1
Laudon, M; Zisapel, N	1
Gan, J; Iuvone, PM	1
Anis, Y; Nir, I; Oaknin-Bendahan, S; Zisapel, N	1
Robertson, AD; Willis, GL	2
Willis, GL	1

Reviews

1 review(s) available for melatonin and ml 23

Article	Year
The role of ML-23 and other melatonin analogues in the treatment and management of Parkinson's disease. Drug news & perspectives, 2005, Volume: 18, Issue:7 Topics: 5-Methoxytryptamine; Animals; Antiparkinson Agents; Disease Models, Animal; Humans; Levodopa; Melatonin; Parkinson Disease	2005

Trials

1 trial(s) available for melatonin and ml 23

Article	Year
Recovery from experimental Parkinson's disease in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride treated marmoset with the melatonin analogue ML-23. Pharmacology, biochemistry, and behavior, 2005, Volume: 80, Issue:1 Topics: 5-Methoxytryptamine; Animals; Behavior, Animal; Callithrix; Cross-Over Studies; Eating; Male; Melatonin; Parkinsonian Disorders; Reaction Time; Recovery of Function	2005

Article

Year

Recovery from experimental Parkinson's disease in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride treated marmoset with the melatonin analogue ML-23.

Pharmacology, biochemistry, and behavior, 2005, Volume: 80, Issue:1

Topics: 5-Methoxytryptamine; Animals; Behavior, Animal; Callithrix; Cross-Over Studies; Eating; Male; Melatonin; Parkinsonian Disorders; Reaction Time; Recovery of Function

2005

Other Studies

9 other study(ies) available for melatonin and ml 23

Article	Year
Effects of short-day photoperiods and of N-(2,4-dinitrophenyl)-5-methoxytryptamine, a putative melatonin antagonist, on melatonin synthesis in the Harderian gland of the Syrian hamster, Mesocricetus auratus. Journal of pineal research, 1990, Volume: 8, Issue:3 Topics: 5-Methoxytryptamine; Acetylserotonin O-Methyltransferase; Acetyltransferases; Analysis of Variance; Animals; Cricetinae; Female; Harderian Gland; Lacrimal Apparatus; Lighting; Male; Melatonin; Mesocricetus; Periodicity	1990
Test of ML23 as an antagonist to the effects of melatonin in the ram. Journal of reproduction and fertility, 1989, Volume: 86, Issue:2 Topics: 5-Methoxytryptamine; Animals; Follicle Stimulating Hormone; Light; Lysine; Male; Melatonin; Reproduction; Serotonin; Testis; Testosterone	1989
A novel melatonin antagonist, N-(2,4-dinitrophenyl)-5-methoxytryptamine neutralizes some effects of melatonin in the female Syrian hamster. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1989, Volume: 191, Issue:4 Topics: 5-Methoxytryptamine; Animals; Cricetinae; Estradiol; Female; Follicle Stimulating Hormone; Luteinizing Hormone; Melatonin; Mesocricetus; Organ Size; Ovary; Pituitary Gland; Progesterone; Prolactin; Serotonin; Thyroxine; Triiodothyronine; Uterus	1989
Failure of N-(2,4-dinitrophenyl)-5-methoxytryptamine (a putative melatonin antagonist) and of N-(3,5-dinitrophenyl)-5-methoxytryptamine to prevent the effects of injections of melatonin in the late afternoon on testicular activity of the golden hamster. The Journal of endocrinology, 1989, Volume: 123, Issue:2 Topics: 5-Methoxytryptamine; Animals; Atrophy; Cold Temperature; Cricetinae; Light; Male; Melatonin; Mesocricetus; Serotonin; Testis	1989
N-(2,4-dinitrophenyl)-5-methoxytryptamine, a novel melatonin antagonist: effects on sexual maturation of the male and female rat and on oestrous cycles of the female rat [corrected]. The Journal of endocrinology, 1988, Volume: 116, Issue:1 Topics: 5-Methoxytryptamine; Administration, Oral; Animals; Estrus; Female; Male; Melatonin; Ovulation; Rats; Receptors, Melatonin; Receptors, Neurotransmitter; Serotonin; Sexual Maturation; Tryptamines	1988
A novel melatonin antagonist affects melatonin-mediated processes in vitro and in vivo. European journal of pharmacology, 1987, Apr-14, Volume: 136, Issue:2 Topics: 5-Methoxytryptamine; Animals; Dopamine; Electric Stimulation; Female; Genitalia, Male; Hypothalamus; Male; Melatonin; Rats; Tryptamines	1987
Melatonin receptor-mediated inhibition of cyclic AMP accumulation in chick retinal cell cultures. Journal of neurochemistry, 1994, Volume: 63, Issue:1 Topics: 1-Methyl-3-isobutylxanthine; 5-Methoxytryptamine; Animals; Cells, Cultured; Chick Embryo; Colforsin; Cyclic AMP; Iodine Radioisotopes; Melatonin; Neurons; Pertussis Toxin; Photoreceptor Cells; Potassium; Receptors, Cell Surface; Receptors, Melatonin; Retina; Second Messenger Systems; Structure-Activity Relationship; Tryptamines; Virulence Factors, Bordetella	1994
Effects of long-term administration of melatonin and a putative antagonist on the ageing rat. Neuroreport, 1995, Mar-27, Volume: 6, Issue:5 Topics: 5-Methoxytryptamine; Aging; Animals; Body Weight; Hypothalamus; Iodine Radioisotopes; Male; Medulla Oblongata; Melatonin; Pons; Random Allocation; Rats; Receptors, Cell Surface; Receptors, Melatonin; Survival Rate; Testosterone; Time Factors	1995
Recovery of experimental Parkinson's disease with the melatonin analogues ML-23 and S-20928 in a chronic, bilateral 6-OHDA model: a new mechanism involving antagonism of the melatonin receptor. Pharmacology, biochemistry, and behavior, 2004, Volume: 79, Issue:3 Topics: 5-Methoxytryptamine; Animals; Male; Melatonin; Naphthalenes; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Receptors, Melatonin; Recovery of Function	2004